Table 1.

Demographic and clinical characteristics for ACS hospitalizations by ICU transfer status

DemographicsNo ICU transfer, n = 175ICU transfer, n = 52P value 
Female sex 93 (53%) 30 (58%) .50 
Mean age (SD), y 28.7 (9.7) 29.7 (10.0) .59 
Non-Hispanic Black 175 (100%) 52 (100%) 
Medical history    
BMI (kg/m2   
Underweight (<18.5) 24 (14%) 12 (23%) .10  
Normal (18.5-24.9) 121 (69%) 23 (44%) 
Overweight (25-29.9) 18 (10%) 9 (17%) .01  
Obese (≥30) 12 (7%) 8 (15%)  
Smoking history   .32  
Never 119 (69%) 27 (53%)  
Former 26 (15%) 14 (27%)  
Current 28 (16%) 10 (20%)  
SCD type   .34§  
Hb SS 123 (70%) 36 (69%)  
Hb SC 13 (7%) 4 (8%)  
Hb Sβ+ 5 (3%) 5 (10%)  
Hb Sβ0 34 (19%) 7 (13%)  
Prior vaso-occlusive event 156 (89%) 46 (90%) .88 
Prior ACS 146 (83%) 47 (90%) .36 
Asthma 68 (39%) 24 (47%) .33 
COPD 1 (1%) 2 (4%) .15 
Splenic sequestration 27 (16%) 5 (10%) .60 
Surgical splenectomy 25 (14%) 5 (10%) .69 
Stroke 22 (13%) 7 (14%) .58 
Current medications    
Home oxygen 26 (15%) 17 (33%) .05 
Steroids 1 (1%) 2 (4%) .20 
Hydroxyurea 95 (54%) 27 (52%) .59 
l-Glutamine 10 (6%) 3 (6%) .98 
Voxelotor 3 (2%) 0 (0%) 
Crizanlizumab 1 (1%) 1 (2%) .38 
Laboratory values at diagnosis, mean (SD)    
White blood cell, ×103/μL 15.9 (6.2) 18.1 (7.6) .09 
Hemoglobin, g/dL 7.7 (1.5) 7.2 (1.5) .12 
Platelets, ×103/μL 369 (164) 284 (136) .002 
Nasal viral positive (%) 14 (11%) 5 (11%) .82 
Clinical outcomes    
ACS-directed antibiotics 172 (98%) 52 (100%) 
Simple transfusion only 121 (69%) 16 (31%) <.001 
Red cell exchange 10 (6%) 35 (67%) <.001 
LOS (SD), d 8.5 (7.4) 12.0 (9.8) .025 
28-day readmission 41 (23%) 11 (23%) .88 
DemographicsNo ICU transfer, n = 175ICU transfer, n = 52P value 
Female sex 93 (53%) 30 (58%) .50 
Mean age (SD), y 28.7 (9.7) 29.7 (10.0) .59 
Non-Hispanic Black 175 (100%) 52 (100%) 
Medical history    
BMI (kg/m2   
Underweight (<18.5) 24 (14%) 12 (23%) .10  
Normal (18.5-24.9) 121 (69%) 23 (44%) 
Overweight (25-29.9) 18 (10%) 9 (17%) .01  
Obese (≥30) 12 (7%) 8 (15%)  
Smoking history   .32  
Never 119 (69%) 27 (53%)  
Former 26 (15%) 14 (27%)  
Current 28 (16%) 10 (20%)  
SCD type   .34§  
Hb SS 123 (70%) 36 (69%)  
Hb SC 13 (7%) 4 (8%)  
Hb Sβ+ 5 (3%) 5 (10%)  
Hb Sβ0 34 (19%) 7 (13%)  
Prior vaso-occlusive event 156 (89%) 46 (90%) .88 
Prior ACS 146 (83%) 47 (90%) .36 
Asthma 68 (39%) 24 (47%) .33 
COPD 1 (1%) 2 (4%) .15 
Splenic sequestration 27 (16%) 5 (10%) .60 
Surgical splenectomy 25 (14%) 5 (10%) .69 
Stroke 22 (13%) 7 (14%) .58 
Current medications    
Home oxygen 26 (15%) 17 (33%) .05 
Steroids 1 (1%) 2 (4%) .20 
Hydroxyurea 95 (54%) 27 (52%) .59 
l-Glutamine 10 (6%) 3 (6%) .98 
Voxelotor 3 (2%) 0 (0%) 
Crizanlizumab 1 (1%) 1 (2%) .38 
Laboratory values at diagnosis, mean (SD)    
White blood cell, ×103/μL 15.9 (6.2) 18.1 (7.6) .09 
Hemoglobin, g/dL 7.7 (1.5) 7.2 (1.5) .12 
Platelets, ×103/μL 369 (164) 284 (136) .002 
Nasal viral positive (%) 14 (11%) 5 (11%) .82 
Clinical outcomes    
ACS-directed antibiotics 172 (98%) 52 (100%) 
Simple transfusion only 121 (69%) 16 (31%) <.001 
Red cell exchange 10 (6%) 35 (67%) <.001 
LOS (SD), d 8.5 (7.4) 12.0 (9.8) .025 
28-day readmission 41 (23%) 11 (23%) .88 

COPD, chronic obstructive pulmonary disorder; HB, hemoglobin; SD, standard deviation.

Boldface values indicate P < .05.

Multilevel logistic regression model coefficient P value.

BMI was compared as underweight vs normal as well as overweight/obese vs normal in multilevel logistic regression models.

Smoking dichotomized into never vs prior/current in multilevel logistic regression model.

§

SCD type dichotomized into SS vs non-SS in multilevel logistic regression model.

or Create an Account

Close Modal
Close Modal